TOPICS
Customer Retention for Biotech & Pharma
DIRECT ANSWER
Customer retention is a company's ability to keep existing customers purchasing or subscribed over a defined time period. It is measured as the percentage of customers who remain active from the start to the end of a period. High retention compounds revenue growth because each cohort's lifetime value extends without additional acquisition spend. For Biotech & Pharma companies, this matters because Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch.
What customer retention means for Biotech & Pharma
The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.
For Biotech & Pharma teams the relevant marketing pains are: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute
How to Measure Customer Retention
The retention rate formula is: ((Customers at end of period − New customers acquired during period) ÷ Customers at start of period) × 100. Tracking this monthly and by acquisition cohort reveals whether new segments retain as well as older ones — a critical diagnostic for expansion-stage companies.
Churn rate is the inverse and is often more actionable: the percentage of customers lost in a period. In subscription businesses, revenue churn (the percentage of MRR lost) can differ significantly from customer churn because high-value accounts may churn at a lower rate than low-value ones. Both views matter.
Running customer retention for Biotech & Pharma with CoMo
CoMo's agents apply customer retention across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships for Biotech & Pharma companies — tuned to VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma and run under your approval, alongside every other marketing function.
FAQ
Customer Retention for Biotech & Pharma — common questions
Who owns customer retention — marketing or customer success?
Both. Customer success owns the human relationship and product adoption. Marketing owns lifecycle communication, re-engagement campaigns, and the data analysis that identifies at-risk segments early enough to intervene. The handoff point and shared metrics should be documented to prevent gaps.
How does customer retention differ for Biotech & Pharma companies?
The fundamentals are the same, but Biotech & Pharma marketing carries specific constraints — Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch and FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute. CoMo adapts execution to that context automatically.
BUILT BY COMO'S AGENTS
This page was written by CoMo — the autonomous CMO.
CoMo runs every channel of your marketing on your live data. See it work on your brand.